Mark J. O’Connor
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Oncology top 10%
- PARP inhibition in cancer therapy
Papers in
- Oncology 13
- PARP inhibition in cancer therapy 10
-
- CRISPR and Genetic Engineering 4
- DNA Repair Mechanisms 4
- Co-authors
- Darren Hodgson (3 shared papers)Woo Ho Kim (2 shared papers)Yung‐Jue Bang (2 shared papers)Xiaolu Yin (2 shared papers)David B. Mount (1 shared paper)Natalie McCormick (1 shared paper)Chio Yokose (1 shared paper)Hyon K. Choi (1 shared paper)
- Journals
- Cancer Research (4 papers)Prehospital Emergency Care (2 papers)Journal of Clinical Oncology (2 papers)Arthritis & Rheumatology (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark J. O’Connor
33 papers receiving 803 citations
Peers
Comparison fields: 5 of 99
- Nephrology 92
- Oncology 300
- Anesthesiology and Pain Medicine 35
- Gastroenterology 33
- Pathology and Forensic Medicine 102
Countries citing papers authored by Mark J. O’Connor
This map shows the geographic impact of Mark J. O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. O’Connor more than expected).
Fields of papers citing papers by Mark J. O’Connor
This network shows the impact of papers produced by Mark J. O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. O’Connor. The network helps show where Mark J. O’Connor may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. O’Connor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 219 | |
| 2 | 2021 | 102 | |
| 3 | 2014 | 79 | |
| 4 | 2017 | 59 | |
| 5 | 2013 | 48 | |
| 6 | 2021 | 40 | |
| 7 | 2011 | 36 | |
| 8 | 2009 | 27 | |
| 9 | 2020 | 22 | |
| 10 | 2013 | 20 | |
| 11 | 2019 | 18 | |
| 12 | 2024 | 15 | |
| 13 | 2018 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2010 | 13 | |
| 16 | 2018 | 12 | |
| 17 | 2017 | 12 | |
| 18 | 2021 | 12 | |
| 19 | 2003 | 10 | |
| 20 | 2016 | 8 |
About Mark J. O’Connor
Mark J. O’Connor is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Endocrinology, Diabetes and Metabolism, having authored 35 papers that have together received 825 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), CRISPR and Genetic Engineering (4 papers), DNA Repair Mechanisms (4 papers), Diabetes Management and Research (3 papers), Genetic Associations and Epidemiology (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Advanced Breast Cancer Therapies (3 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Nephrology (92 citations), Oncology (300 citations), Anesthesiology and Pain Medicine (35 citations), Gastroenterology (33 citations) and Pathology and Forensic Medicine (102 citations). Mark J. O’Connor has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Darren Hodgson, Woo Ho Kim, Yung‐Jue Bang, Xiaolu Yin, David B. Mount, Natalie McCormick, Chio Yokose, Hyon K. Choi, Tony R. Merriman and Y. Choi. Their work appears in journals such as Cancer Research, Prehospital Emergency Care, Journal of Clinical Oncology, Arthritis & Rheumatology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.